Published March 14, 2026 | Version v1
Presentation Open

Article Review: Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML

  • 1. School of Medicine, Pontificia Universidad Javeriana Cali, Cali 760031, Colombia
  • 2. Student Research Group in Microbiology, Immunology, and Cancer, Pontificia Universidad Javeriana Cali, Cali 760031, Colombia

Files

Review Article Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML.pdf